Drug Discovery
Isomorphic Labs Raises $2B to Prove AI Can Compress Drug Discovery Timelines
Google DeepMind's spinout secures what could be the largest AI-drug discovery financing ever, but delayed clinical trials test whether algorithms can match biology's pace.
Isomorphic Labs Enters Human Trials With AI-Designed Drugs, Testing Industry’s $3 Billion Bet
DeepMind spinoff's 2026 clinical trials mark first major test of whether machine learning can genuinely reduce drug failure rates beyond early-stage screening.
Eli Lilly’s $2.75 Billion Insilico Deal Marks Enterprise AI’s Shift From Hype to Production
Big Pharma's largest generative AI partnership validates vertical specialization over generalist models—and signals that geopolitics won't block deals where ROI is measurable.
What Is Quantum Computing and Why Nations Are Racing to Control It
As French startup Pasqal targets a $2 billion SPAC listing, the global race to achieve quantum advantage intensifies across competing hardware platforms and trillion-dollar applications.